Christopher G Kanakry, M.D.

Trials

Studies that name Christopher G Kanakry, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:23 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07162038 · Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

  National Cancer Institute (NCI) · recruiting · Hematologic Malignancies, Hematologic Neoplasms · principal investigator
• N/A
  NCT06856226 · Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

  National Cancer Institute (NCI) · recruiting · Leukemia, Lymphoma, Hematologic Malignancy · principal investigator
• Ph1/Ph2
  NCT05436418 · The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

  National Cancer Institute (NCI) · recruiting · Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation · principal investigator
• Ph1/Ph2
  NCT05327023 · Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

  National Cancer Institute (NCI) · recruiting · Hematologic Neoplasms · principal investigator
• Ph1/Ph2
  NCT04959175 · Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

  National Cancer Institute (NCI) · recruiting · Hematologic Neoplasms · principal investigator
• Ph1/Ph2
  NCT03983850 · Optimizing PTCy Dose and Timing

  National Cancer Institute (NCI) · active not recruiting · Graft Versus Host Disease, Hematologic Neoplasms · principal investigator
• Ph2
  NCT01338987 · Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

  National Cancer Institute (NCI) · completed · Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.